Commercialize Phase
Okom Logo

Okom Wrks Labs

Regenerative Building Materials

Reimagining the built environment one mycelium brick at a time

What They Do

Okom creates structural mycelium bio-composites that have the potential to outperform traditional building materials in cost, performance, and environmental impact. By integrating mycelium with agricultural and textile waste, Okom produces moldable, structural biomaterials that are regenerative by design—transforming waste streams into high-value building products that sequester carbon and reduce environmental footprint.

Milestones & Traction

Building the future of materials

$850K+
Total Capital Raised
2
Patents Granted
$375K
Commercial Demo Project
3
Key Partnerships

Products & Innovation

Modular Mycelium Building Blocks

Modular Building Blocks

Structural mycelium components designed for versatile construction applications

Mycelium Chair Sculpture

Design Showcase

Mycelium furniture demonstrating structural integrity and aesthetic versatility

AXA Collaboration

Strategic Partnerships

Collaboration with AXA-XL to bring mycelium materials to commercial markets

Advisory & Execution Support

Accelerating commercialization

Commercialization Strategy

Restructured Okom's business model to focus on a sustainable, scalable path to profitability.

Fundraising Support

Guided investment structure, cap table negotiations, WeFunder campaign setup, and non-dilutive funding efforts.

Manufacturing Optimization

Helped relocate facilities, reduce costs, and identify manufacturing partners.

Partnership Development

Facilitated collaboration with MycoWorks to convert waste into input material and share knowledge.

Next Project

MycoNaut